Table 1 Comparison of patient characteristics in CORTICUS and the study of Annane and colleagues.
From: CORTICUS: The end of unconditional love for steroid use?
Characteristic | Annane | CORTICUS |
|---|---|---|
SAPS II mean (placebo/treatment) | 57/60 | 49/50 |
Control group mortality | 61% | 32% |
Corticotropin non-responders | 77% | 47% |
Admission category – medical | 60% | 35% |
Hospital-acquired infection | 21% | 47% |
Post-surgical infection | 16% | 61% |
Abdominal infection | 16% | 49% |